Literature DB >> 871863

Acetylator phenotype in diabetic neuropathy.

E H McLaren, A C Burden, P J Moorhead.   

Abstract

The proportions of slow and fast acetylators in a group of diabetics with symptomatic peripheral neuropathy were compared with those in a group of diabetics who had had the disease for at least 10 years without developing neuropathy. There was a significantly higher proportion of fast acetylators in the group of diabetics without neuropathy than in those with neuropathy or in the normal population. Hence genetic factors separate from the diabetic diathesis may determine the development of neuropathy in any particular diabetic.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871863      PMCID: PMC1630776          DOI: 10.1136/bmj.2.6082.291

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  Genetic control of isoniazid metabolism in man.

Authors:  D A EVANS; K A MANLEY; V A McKUSICK
Journal:  Br Med J       Date:  1960-08-13

2.  Isoniazid neuropathy in man: quantitative electron microscope study.

Authors:  J Ochoa
Journal:  Brain       Date:  1970       Impact factor: 13.501

3.  Pathology of diabetic neuropathy.

Authors:  J S Chopra; T Fannin
Journal:  J Pathol       Date:  1971-07       Impact factor: 7.996

4.  An improved and simplified method of detecting the acetylator phenotype.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1969-12       Impact factor: 6.318

5.  The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients.

Authors:  M J Mattila; H Tiitinen
Journal:  Ann Med Exp Biol Fenn       Date:  1967
  5 in total
  17 in total

1.  Acetylation pharmacogenetics and renal function in diabetes mellitus patients.

Authors:  S O Banjoko; K S Akinlade
Journal:  Indian J Clin Biochem       Date:  2010-08-25

2.  The effect of glucose on acetylation status.

Authors:  D Suhardjono; J Boutagy; G M Shenfield
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

3.  Genetic and metabolic studies in diabetic neuropathy.

Authors:  A J Boulton; R C Worth; J Drury; C A Hardisty; E Wolf; A G Cudworth; J D Ward
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

Review 4.  Do genetic factors play a role in the pathogenesis of diabetic microangiopathy?

Authors:  J Barbosa; B Saner
Journal:  Diabetologia       Date:  1984-11       Impact factor: 10.122

5.  Hepatic acetylator phenotype in porphyria cutanea tarda.

Authors:  J M Ladero; R Enriquez de Salamanca; S Chinarro
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

Review 6.  Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.

Authors:  P O'Connor; J Feely
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447

Review 7.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

8.  Diabetic dimorphism according to acetylator status.

Authors:  A W Burrows; T D Hockaday; J I Mann; J G Taylor
Journal:  Br Med J       Date:  1978-01-28

9.  Genetic and metabolic risk factors for the development of late complications in type I (insulin-dependent) diabetes.

Authors:  A E Pontiroli; A Calderara; L Bonisolli; P Maffi; A De Pasqua; A Margonato; G Radaelli; G Gallus; G Pozza
Journal:  Acta Diabetol Lat       Date:  1986 Oct-Dec

10.  Association studies between Type 1 (insulin-dependent) diabetes and 27 genetic markers: lack of association between Type 1 diabetes and Kidd blood group.

Authors:  S E Hodge; C E Anderson; K Neiswanger; R Rubin; R S Sparkes; M C Sparkes; M Crist; M A Spence; P I Terasaki; D L Rimoin
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.